Latest News about CYTK
Recent news which mentions CYTK
FDA Rejects Cytokinetics' Heart Failure Treatment Candidate
March 01, 2023
Tickers
CYTK
From Benzinga
Earnings Scheduled For March 1, 2023
March 01, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2023
February 17, 2023
From Benzinga
From Benzinga
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
From Benzinga
Tesla To $175? Here Are 10 Other Price Target Changes For Friday
December 23, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2022
December 20, 2022
From Benzinga
Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session
December 14, 2022
From Benzinga
REV Group, Avidity Biosciences And Some Other Big Stocks Moving Higher On Wednesday
December 14, 2022
From Benzinga
Top Stories Today: Jack Dorsey Not Exactly Impressed With Elon Musk's Twitter; Binance Sees $3B Outflow In 7 Days..
December 14, 2022
From Benzinga
FDA Adcomm Gives Thumbs Down To Cytokinetics' Heart Failure Candidate
December 14, 2022
Tickers
CYTK
From Benzinga
Best stock picks for 2023: Here are Wall Street analysts’ most heavily favored choices
December 13, 2022
From MarketWatch
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
December 02, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.